SCHEMBL5774445

SCHEMBL5774445

Cc1cc2c(nc(C(C)C)n2-c2c[c]ccc2)c(C)n1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27597632 0.81 PTGER4 (0.41) NR1H2NR1H3
SCHEMBL27581313 0.80 KDM4E (0.35) NR1H2NR1H3
SCHEMBL7103580 0.80
SCHEMBL27597664 0.76 PTGER4 (0.36)
SCHEMBL27579815 0.76 TLR7 (0.34) NR1H2NR1H3
SCHEMBL6427478 0.74 PTGER4 (0.37)
SCHEMBL27618333 0.73
SCHEMBL8139492 0.72 BACE1 (0.35) NR1H2NR1H3
SCHEMBL27597647 0.65 GPR4 (0.41)
SCHEMBL27695518 0.64 PTGER4 (0.46) NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326864-B1 ARYL OR HETEROARYL FUSED IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS PFIZER PHARMA (JP) 2006-03-15 EP disclosed
EP-1499305-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES Pfizer Japan Inc. (JP) 2005-01-26 EP disclosed
WO-2003086371-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES PFIZER JAPAN INC. (JP) 2003-10-23 WO disclosed